Although the clinical literature abounds with promises the limited-acting barbiturates are exceptional for making rest whilst the intermediate-performing compounds are more practical in keeping rest, managed experiments have didn't exhibit these differential effects. As a result, as rest remedies, the barbiturates are of minimal value further than